LUMOS PHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lumos Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2024.
- Lumos Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 8.33M shares, a 4.38% increase year-over-year.
- Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8.15M shares, a 2.73% decline from 2022.
- Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8.37M shares, a 0.47% increase from 2021.
- Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 8.33M shares, a 23% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)